Reauthorization of PDUFA : What It Means for Jobs, Innovation, and Patients.

FDA User Fee Agreements : Improving Medical Product Regulation and Innovation for Patients.
Published: (2017)

Prioritizing Public Health : The FDA's Role in the Generic Drug Marketplace : Special Hearing.
Published: (2016)

Examining FDA's Prescription Drug User Fee Program.
Published: (2017)

The Food and Drug Administration Safety and Innovation Act (FDASIA, P.L. 112-144) /
by: Thaul, Susan
Published: (2018)

Reauthorization of PDUFA : what it means for jobs, innovation, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 1, 2012.
Published: (2012)

FDA User Fees 2012 : How Innovation Helps Patients and Jobs.
Published: (2012)

Reviewing FDA's Implementation of FDASIA.
Published: (2013)

Reauthorization of Animal Drug User Fees : ADUFA and AGDUFA.
Published: (2013)

Examining FDA's Generic Drug and Biosimilar User Fee Programs.
Published: (2017)

FDA Reauthorization Act of 2017 (FDARA, P.L. 115-52) /
by: Sarata, Amanda K.
Published: (2018)

Access to unapproved drugs : FDA policies on compassionate use and emergency use authorization /
by: Thaul, Susan
Published: (2018)

PDUFA V : medical innovation, jobs, and patients : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, first session, July 7, 2011.
Published: (2012)

Committee prints on administration legislative proposals on the Animal Drug User Fee Act Amendments of 2008 and the Animal Generic Drug User Fee Act of 2008 : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, June 5, 2008.
Published: (2008)

Proposed FDA user fee acts : Generic Drug User Fee Amendments of 2012 (GDUFA) and Biosimilar User Fee Act of 2012 (BSUFA) /
by: Thaul, Susan, et al.
Published: (2019)

Medical Device User Fee and Modernization Act (MDUFMA) reauthorization /
by: Williams, Erin D.
Published: (2019)

FDA User Fee Agreements : Strengthening FDA and the Medical Products Industry for the Benefit of Patients.
Published: (2012)

Generic drugs and GDUFA reauthorization : in brief /
by: Johnson, Judith A. (Judith Ann), 1957-
Published: (2018)

Drug Safety : An Update from the Food and Drug Administration.
Published: (2010)

Examining the Increase in Drug Shortages.
Published: (2011)

Food and cosmetic provisions of the Food and Drug Administration Globalization Act discussion draft legislation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 24, 2008.
Published: (2008)

H.R. 339, the Northern Mariana Islands Economic Expansion Act.
Published: (2017)

Definitions and standards for food products.
Published: (1932)

[Budget activities of Veterans Administration; text of order].
Published: (1930)

[Finance activities of Veterans Administration; text of order].
Published: (1930)

Animal Drug User Fee Agreements : Advancing Animal Health for the Public.
Published: (2013)

Examining FDA's Medical Device User Fee Program.
Published: (2017)

The Cost of Prescription Drugs : How the Drug Delivery System Affects What Patients Pay.
Published: (2017)

Discussion draft of the Food and Drug Administration Globalization Act legislation : device and cosmetic safety provisions : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, May 14, 2008.
Published: (2008)

FDA regulation of medical devices, including the status of breast implants : joint hearing before the Subcommittee on Human Resources and Intergovernmental Relations and the Subcommittee on National Economic Growth, Natural Resources, and Regulatory Affairs of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, first session, August 1, 1995.
Published: (1996)

FDA User Fees : Advancing Public Health.
Published: (2011)

Review of the Proposed Generic Drug and Biosimilars User Fees and Further Examination of Drug Shortages.
Published: (2012)

Examining FDA's Prescription Drug User Fee program : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session, March 22, 2017.
Published: (2018)

Drug safety: FDA should take additional steps to improve its Foreign Inspection Program : report to congressional requesters.
Published: (2022)

Continuing America's Leadership in Medical Innovation for Patients.
Published: (2015)

FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008.
Published: (2008)

China's Healthcare Sector, Drug Safety, and the U.S.-China Trade in Medical Products.
Published: (2014)